<?xml version="1.0" encoding="UTF-8"?>
<p id="p0200">Representatives of exopolysaccharides (EPS) producing strains of the genera 
 <italic>Streptococcus</italic>, 
 <italic>Lactococcus</italic>, 
 <italic>Lactobacillus</italic>, 
 <italic>Leuconostoc</italic>, 
 <italic>Pediococcus</italic>, and 
 <italic>Weissella</italic> have been well studied for immunostimulating properties. The EPSs extracted from lactic acid bacteria of the genera 
 <italic>Pediococcus</italic>, 
 <italic>Leuconostoc</italic>, and 
 <italic>Lactobacillus</italic> significantly proved to produce anti-adenovirus effects in cell line studies (
 <xref rid="bb0125" ref-type="bibr">Biliavska et al., 2019</xref>). Other microbial metabolites like spongouridine, spongothymidine, statins, myriocin, NA255, and cyclosporine were reported to have antiviral activities against HSV1,2, HBV, HIV, influenza virus, HCV, and coronaviruses (
 <xref rid="bb1045" ref-type="bibr">Nkongolo et al., 2014</xref>). Antiviral attributes of bacteria associated bioactive compounds are summarized in 
 <xref rid="t0025" ref-type="table">Table 5</xref> .
</p>
